Tall-cell variant of papillary thyroid cancer: Disregarded entity?

World Journal of Surgery

Volumn 21, Issue 1, 1997, Pages 15-21

  Ruter A ^a   Nishiyama, R ^b   Lennquist, S ^a  

^a LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^b MAINE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; THYROGLOBULIN;

ADULT; AGED; ARTICLE; ASPIRATION CYTOLOGY; CANCER CLASSIFICATION; CANCER INCIDENCE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA CONTENT; FEMALE; HUMAN; HUMAN TISSUE; MALE; METASTASIS; PLOIDY; PROGNOSIS; RECURRENT DISEASE; THYROGLOBULIN BLOOD LEVEL; THYROID PAPILLARY CARCINOMA; THYROIDECTOMY; TREATMENT OUTCOME; TUMOR DIFFERENTIATION;

AGED; CARCINOMA, PAPILLARY; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; THYROGLOBULIN; THYROID NEOPLASMS; TREATMENT OUTCOME;

EID: 1842332175     PISSN: 03642313     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002689900187     Document Type: Article

References (29)

1. Chan, J.: Papillary carcinoma of the thyroid: classical and variants. Histol. Histopathol. 5:241, 1990
2. Vickery, A., Wang, C., Walker, A.: Treatment of intrathyroidal papillary carcinoma of the thyroid. Cancer 60:2587, 1987
3. Grant, C., Hay, I., Gough, I., Bergstralh, E., Goellner, J., McConahey, W.: Local recurrence in papillary thyroid carcinoma: is extent of surgical resection important? Surgery 104:954, 1988
4. McHenry, C., Jarosz, H., Lawrence, A., Paloyan, E.: Improving postoperative recurrence rates for carcinoma of the thyroid gland. Surg. Gynecol. Obstet. 169:429, 1989
5. Mazzaferri, E., Young, R.: Papillary thyroid carcinoma: a 10 year follow-up report of the impact of therapy in 576 patients. Am. J. Med. 70:511, 1981
6. Schindler, A-M., van Melle, G., Evequoz, B., Scazziga, B.: Prognostic factors in papillary carcinoma of the thyroid. Cancer 68:324, 1991
7. Johnsson, T., Lloyd, R., Thompson, N., Beierwaltes, W., Sisson, J.: Prognostic implications of the tall cell variant of papillary thyroid carcinoma. Am. J. Surg. Pathol. 12:22, 1988
8. Hawk, W., Hazard, J.: The many appearances of papillary carcinoma of the thyroid. Cleve. Clin. Q. 43:207, 1976
9. Kramer, J., Wells, S.: Thyroid carcinoma. Adv. Surg. 22:195, 1989
10. Wingren, S., Hatschek, T., Stål, O., Boeryd, B., Nordensköld, B.: Comparison of static and flow cytofluorometry for estimation of DNA index and S-phase fraction in fresh and paraffin-embedded breast carcinoma tissue. Acta Oncol. 27:793, 1988
11. TNM Classification of Malignant Tumors. Geneva Union Internationale Contre le Cancer (4th ed.), 1987
12. Andry, G., Chantrain, G., van Glabbeke, M., Dor, P.: Papillary and follicular thyroid carcinoma: individualization of the treatment according to the prognosis of the disease. Eur. J. Clin. Oncol. 24:1641, 1988
13. McConahey, W., Hay, I., Woolner, L., van Heerden, J., Taylor, W.: Papillary thyroid cancer treated at the Mayo Clinic, 1946 through 1970: initial manifestations, pathologic findings, therapy, and outcome. Mayo Clin. Proc. 61:978, 1986
14. Spires, J., Robbins, T., Luna, A., Byers, R.: Metastatic papillary carcinoma of the thyroid: the significance of extranodal extension. Head Neck 11:242, 1989
15. Hay, I., Grant, C., Taylor, W., McConahey, W.: Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: a retrospective analysis of surgical outcome using a novel prognostic scoring system. Surgery 102:1088, 1987
16. Clark, O., Levin, K., Zeng, Q., Greenspan, F., Siperstein, A.: Thyroid cancer: the case for total thyroidectomy. Eur. J. Clin. Oncol. 24:305, 1988
17. Röher, H-D., Goretzki, P.: Management of goiter and thyroid nodules in an area of endemic goiter. Surg. Clin. North Am. 67:233, 1987
18. Tollefsen, R., Shah, J., Huvos, A.: Papillary carcinoma of the thyroid. Am. J. Surg. 124:468, 1971
19. Sarda, A., Bal, S., Kapur, M.: Near-total thyroidectomy for carcinoma of the thyroid. Br. J. Surg. 76:90, 1989
20. Grant, C., Hay, D.: Local recurrence of papillary thyroid carcinoma after unilateral or bilateral thyroidectomy. Wien. Klin. Wochenschr. 11:342, 1988
21. Szantó, J., Borbala, V., Sinkovics, I., Karika, Z., Daubner, K., Péter, I., Kazatsay, I., Eckhardt, S.: Postoperative thyroglobulin level determination to follow up patients with highly differentiated thyroid cancer. Oncology 46:99, 1989
22. Ericsson, U-B., Tegler, L., Lennquist, S., Borup-Christensen, S., Ståhl, E., Thorell, J.: Serum thyroglobulin in differentiated thyroid carcinoma. Acta Chir. Scand. 150:367, 1984
23. Hrafnkclsson, J., Stahl, O., Enström, S., Jonasson, J., Björnsson, J., Olafsdottir, K., Nordensköld, B.: Cellular DNA pattern, S-phase frequency and survival in papillary thyroid cancer. Acta Oncol. 27:329, 1988
24. Cohn, K., Bäckdahl, M., Forsslund, G., Auer, G., Lundell, G., Lowhagcn, T., Tallroth, E., Willems, J.-S., Zctterberg, A., Granberg, P.-O.: Prognostic value of nuclear DNA content in papillary thyroid carcinoma. World J. Surg. 5:470, 1989
25. Joensuu, H., Klemi, P., Eerola, E., Tuominen, J.: Influence of cellular DNA content on survival in differentiated thyroid cancer. Cancer 58: 2462, 1986
26. Lennquist, S.: Surgical strategy in thyroid carcinoma: a clinical review. Acta Chir. Scand. 152:321, 1985
27. Hedley, D., Friedlander, M., Taylor, I., Rugg, C., Musgrove, E.: Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry, J. Histochem. Cytochem. 31:1333, 1983
28. Bonjer, HJ., Bruining, H., Birkenhager, J., Nishiyama, R., Jones, M., Bagwell, B.: Clinicopathologic study in primary hyperparathyroidism. World J. Surg. 16:737, 1992
29. Lore, J.: Single and multigland disease in primary hyperparathyroidism: clinical follow-up, histopathology and flow cytometric DNA analysis. World J. Surg. 16:737, 1992